Dietary Interventions and Supplements Gain Traction in Managing Breast Cancer Treatment Side Effects
Recent clinical trials and patient reports highlight dietary strategies like the Mediterranean diet and omega-3 supplements for alleviating aromatase inhibitor-induced joint pain, amid calls for impro...
NanoHerb Therapeutics’ cubosome-based arthritis treatment receives FDA Fast Track status, while University of Milan research demonstrates 40% greater inflammation reduction than NSAIDs with zero...
Exploring the controversial rise of BPC-157 peptide therapy for injury recovery amid conflicting preclinical evidence, regulatory warnings, and growing off-label use in athletics. A synthetic peptide ...
New clinical studies demonstrate time-restricted eating’s potential to slow Huntington’s progression through circadian optimization and enhanced autophagy, with major research institutions...
Recent studies reveal omega-3s reduce arthralgia by 32% in aromatase inhibitor users, while curcumin cuts hot flashes by 41%. NCCN guidelines now recommend Mediterranean diets to counter metabolic shi...
Emerging research demonstrates herbal cubosomes’ superior anti-inflammatory drug delivery for arthritis, with recent trials showing 68% pain reduction and novel pH-responsive targeting developed...
HTRecNet’s AI achieves 94% accuracy in detecting liver cancers, reduces diagnostic delays by 3 weeks, and cuts unnecessary biopsies by 40% according to recent clinical trials. A new AI system re...
Recent studies show BPC-157’s potential in treating tendon and muscle injuries, but regulatory hurdles and off-label use raise ethical questions in sports medicine. Emerging research on intraven...
Recent studies show omega-3 and vitamin D supplements can significantly reduce arthralgia in breast cancer patients undergoing endocrine therapy, with personalized nutrition emerging as a key strategy...
Recent studies suggest time-restricted eating may delay Huntington’s disease symptoms by enhancing mitochondrial function and autophagy, with human trials currently underway. Emerging research indic...
